NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis

Pediatric Cardiology

Volumn 27, Issue 1, 2006, Pages 87-90

  Nasser, N ^a   Perles, Z ^b   Rein, A J J T ^b   Nir, A ^c  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Children natriuretic peptides; Dilated cardiomyopathy; Left ventricular dysfunction; Myocarditis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MILRINONE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADOLESCENT; ARTICLE; BLOOD; CHILD; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; DRUG COMBINATION; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFANT; MALE; MYOCARDITIS; PREDICTION AND FORECASTING; PRESCHOOL CHILD; REFERENCE VALUE; STATISTICS;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIGOXIN; DIURETICS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MILRINONE; MYOCARDITIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; STATISTICS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745479685     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-005-1027-z     Document Type: Article

References (22)

1. Batra A, Lewis A (2001) Acute myocarditis. Curr Opin Pediatr 13:234-239 (Pubitemid 32505682)
2. Baugman KL (2002) B-type natriuretic peptide - a window to the heart. N Engl J Med 347:158-159
3. Bettuzzi MG, Colaneri M, Ricciotti R, et al. (2004) Plasma natriuretic peptides in neonates and children with congenital heart disease: correlation with ventricular function, heart failure symptoms and cardiac anatomy [abstract]. Cardiol Young 14(Suppl 2):34
4. Calabrese F, Thiene G (2003) Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 60:11-25 (Pubitemid 38373472)
5. Connolly D, Rutkowski M, Auslender M, Artman M (2001) The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 138:644-648 (Pubitemid 32417662)
6. Drucker NA, Newburger JW (1997) Viral myocarditis: diagnosis and management. Adv Pediatr 44:144-171
7. Espiner EA, Richards AM, Yandle TG, Nicholls MG (1995) Natriuretic hormones. Endocrinol Metab Clin North Am 24:481-509
8. Friedman RA, Schowengerdt KO, Towbin JA (1998) Myocarditis. In: Garson A, Bricker JT, Fischer D, Neish S (eds) The Science and Practice of Pediatric Cardiology, 2nd edn, Willams & Wilkins, Baltimore, pp 1777-1794
9. Karl J, Borgya A, Gullusser A, et al. (1999) Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scan J Clin Lab Invest 59(Suppl 230):177-181 (Pubitemid 29279370)
10. Lubien E, DeMaria A, Krishnaswamy P, et al. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595-601 (Pubitemid 34123434)
11. Mair J, Hammerer-Lercher A, Puschendorf B (2001) The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39:571-588 (Pubitemid 32725741)
12. Maron BJ, Isner JM, McKenna WJ (1994) Task force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol 24:845-899
13. Masson S, Vago T, Baldi G, et al. (2002) Comparative measurement of N-terminal-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 40:761-763
14. Matitiau A, Perez-Atayde A, Sanders SP, et al. (1994) Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics and histology at the time of diagnosis. Circulation 90:1310-1318 (Pubitemid 24284452)
15. McGeoch G, Lainchbury J, Town GI, et al. (2002) Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Failure 4:479-483 (Pubitemid 36564967)
16. Mir TS, Marohn S, Laer S, et al. (2002) Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110:e76
17. Nir A, Bar-Oz B, Perles Z, et al. (2004) N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in heart diseases. Acta Paediatr 93:603-607 (Pubitemid 38570224)
18. Ohuchi H, Takasugi H, Ohashi H, et al. (2003) Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 108:2368-2376 (Pubitemid 37413544)
19. Richards AM, Doughty R, Nicholls G, et al. (2001) Australia-New Zealand heart failure group. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Prognostic utility and prediction of benefit from carvedilol in chronic left ventricular dysfunction. J Am Coll Cardiol 37:1781-1787 (Pubitemid 32499959)
20. Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249-254 (Pubitemid 36995093)
21. Tisseres P, Aggoun Y, Sierra J, et al. (2004) Comparison of the New York Heart Association (NYHA), Ross, and Pediatric Heart Failure Index (PHFI) classifications in children with left ventricular dysfunction secondary to valvular disease. Biochemical and echocardiographic correlation [abstract]. Cardiol Young 14(Suppl 2):36
22. Towbin JA (1999) Pediatric myocardial disease. Pediatr Clin North Am 46:289-312